PRLD Competitors & Alternatives
Compare Prelude Therapeutics Inc with similar stocks in the same industry
Biotechnology
PRLD
Main Stock$3.67
Tradestie Score
54
Market Cap
$85.47M
Revenue Growth
0.4%
Analyst Upside
+150.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$4.19
|
$332.96M | - | 69 | Compare |
|
REPL
Replimune Group, Inc.
|
$13.07
|
$328.62M | - | 65 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.24
|
$307.12M | - | 42 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.18
|
$304.12M | - | 54 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.12
|
$297.23M | - | 55 | Compare |
|
OMER
Omeros Corporation
|
$18.61
|
$281.75M | 11.2 | 54 | Compare |
|
FHTX
Foghorn Therapeutics Inc. Common Stock
|
$2.02
|
$278.69M | - | 38 | Compare |
|
DBVT
DBV Technologies S.A.
|
$10.55
|
$275.54M | - | 42 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.50
|
$275.13M | - | 41 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.69
|
$269.08M | 0.1 | 72 | Compare |
More PRLD Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry